Response and Outcomes of Third-Line Tyrosine Kinase Inhibitor Therapy on Patients with Chronic Phase Chronic Myeloid Leukemia
Year: 2017
Type: article
Study design: Observational Study
Source: Blood
Authors: Maliha Khan, Hagop M. Kantarjian, Jing Ning, Mary Akosile, Wen Li, Gautam Borthakur, Nitin Jain, Courtney D. DiNardo, William G. Wierda, Farhad Ravandi, Guillermo Garcia‐Manero, Marina Konopleva, Tapan M. Kadia, Naveen Pemmaraju, Philip A. Thompson, Naval Daver, Elias Jabbour, Jorge E. Cortés
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2921168312